Apurinic/apyrimidinic endonuclease is inversely associated with response to radiotherapy in pediatric ependymoma

International Journal of Cancer

Volumn 129, Issue 10, 2011, Pages 2370-2379

  Bobola, Michael S ^a,b   Jankowski, Pawel P ^b,c   Gross, Mary E ^b   Schwartz, Jeffery ^a   Finn, Laura S ^b,d   Blank, A ^d   Ellenbogen, Richard G ^a,b   Silber, John R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ray resistance; Ape1 Ref 1; brain tumor; DNA repair

Indexed keywords

ANTINEOPLASTIC AGENT; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA REPAIR PROTEIN APE1; DNA REPAIR PROTEIN REF1; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CANCER CELL; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CHILD; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; ENZYME ACTIVITY; ENZYME REPRESSION; EPENDYMOMA; FEMALE; GLIOMA; HAZARD RATIO; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MEDULLOBLASTOMA; MONOTHERAPY; OVERALL SURVIVAL; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FOLDING; RADIOSENSITIVITY; SCHOOL CHILD; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR LOCALIZATION;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; DISEASE-FREE SURVIVAL; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; EPENDYMOMA; FEMALE; HUMANS; INFANT; MALE; RADIATION TOLERANCE;

EID: 80052967569     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25900     Document Type: Article

References (29)

1. Merchant TE, Fouladi M,. Ependymoma: new therapeutic approaches including radiation and chemotherapy. J Neurooncol 2005; 75: 287-99. (Pubitemid 43019484)
2. Kilday JP, Rahman R, Dyer S, Ridley L, Lowe J, Coyle B, Grundy R,. Pediatric ependymoma: biological perspectives. Mol Cancer Res 2009; 7: 765-86.
3. Poppleton H, Gilbertson RJ,. Stem cells of ependymoma. Br J Cancer 2007; 96: 6-10. (Pubitemid 46094631)
4. Mack SC, Taylor MD,. The genetic and epigenetic basis of ependymoma. Childs Nerv Syst 2009; 25: 1195-201.
5. Tamburrini G, D'Ercole M, Pettorini BL, Caldarelli M, Massimi L, Di Rocco C,. Survival following treatment for intracranial ependymoma: a review. Childs Nerv Syst 2009; 25: 1303-12.
6. Zacharoulis S, Moreno L,. Ependymoma: an update. J Child Neurol 2009; 24: 1431-8.
7. Ridley L, Rahman R, Brundler MA, Ellison D, Lowe J, Robson K, Prebble E, Luckett I, Gilbertson RJ, Parkes S, Rand V, Coyle B, et al. Children's Cancer and Leukaemia Group Biological Studies Committee. Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. Neuro Oncol 2008; 10: 675-89.
8. Ward JF,. The complexity of DNA damage: relevance to biological consequences. Int J Radiat Biol 1994; 66: 427-32. (Pubitemid 24369143)
9. O'Driscoll M, Jeggo PA,. The role of double-strand break repair-insights from human genetics. Nat Rev Genet 2006; 7: 45-54. (Pubitemid 41828947)
10. Breen AP, Murphy JA,. Reactions of oxyl radicals with DNA. Free Radic Biol Med 1995; 18: 1033-77.
11. Drabløs F, Feyzi E, Aas PA, Vaagbø CB, Kavli B, Bratlie MS, Peña-Diaz J, Otterlei M, Slupphaug G, Krokan HE,. Alkylation damage in DNA and RNA - repair mechanisms and medical significance. DNA Repair 2004; 3: 1389-407. (Pubitemid 39221738)
12. Abbotts R, Madhusudan S,. Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer. Cancer Treat Rev 2010, 36: 425-35.
13. Demple B, Harrison L,. Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem 1994, 63: 915-48. (Pubitemid 24218652)
14. Evans AR, Limp-Foster M, Kelley MR,. Going APE over ref-1. Mutat Res 2000, 461: 83-108.
15. Bobola MS, Emond MJ, Blank A, Meade EH, Kolstoe DD, Berger MS, Rostomily RC, Silbergeld DL, Spence AM, Silber JR,. Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapy. Clin Cancer Res 2004, 10: 7875-83. (Pubitemid 39587526)
16. Bobola MS, Finn LS, Ellenbogen RG, Geyer JR, Berger MS, Braga JM, Meade EH, Gross ME, Silber JR,. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin Cancer Res 2005, 11: 7405-14.PMID: 16243814 (Pubitemid 41507701)
17. 6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics. Cancer Res 1998, 58: 1068-73. (Pubitemid 28182481)
18. 6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines. Clin Cancer Res, 2005 11: 2747-55. (Pubitemid 40569477)
19. 6-methylguanine-DNA methyltransferase to monofunctional alkylating-agent resistance in human brain tumor-derived cell lines. Mol Carcinog 1995, 13: 70-80.
20. Hall EJ, Giaccia AJ,. Radiobiology for the Radiologist, 6th ed., Philidelphia: Lippincott, Wiiliams and Wilkins, 2006.
21. McGuire CS, Sainani KL, Fisher PG,. Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg 2009; 110: 725-9.
22. Louis N, Ohgaki, H, Wiestler, OD, Cavenee, WK,. WHO Classification of Tumors of the Central Nervous System, 3rd ed., WHO Press, Geneva, 2007.
23. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR,. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009; 11: 601-20.
24. Silber JR, Bobola MS, Blank A, Schoeler KD, Haroldson PD, Huynh MB, Kolstoe DD,. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress. Clin Cancer Res 2002, 8: 3008-18. (Pubitemid 35025751)
25. Hall JL, Wang X, Van Adamson, Zhao Y, Gibbons GH,. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways. Circ Res 2001; 88: 1247-53. (Pubitemid 32587840)
26. Zawahir Z, Dayam R, Deng J, Pereira C, Neamati N,. Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors. J Med Chem 2009; 52: 20-32.
27. Bapat A, Glass LS, Luo M, Fishel ML, Long EC, Georgiadis MM, Kelley MR,. Novel small molecule inhibitor of Ape1 endonuclease blocks proliferation and reduces viability of glioblastoma cells. J Pharmacol Exp Ther 2010; 334: 988-98.
28. Shimizu N, Sugimoto K, Tang J, Nishi T, Sato I, Hiramoto M, Aizawa S, Hatakeyama M, Ohba R, Hatori H, Yoshikawa T, Suzuki F, et al. High-performance affinity beads for identifying drug receptors. Nat Biotechnol 2000; 18: 877-81. (Pubitemid 30640915)
29. Veiseh O, Gunn JW, Zhang M,. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010; 62: 284-304.